Field Story
2022: celebrating milestones, innovations and making a difference globally
December 30, 2022
This article decribes the protocol for the dose-finding trial which is conducted in 2019 in order to provide evidence for the guideline on weekly folic acid supplementation in menstruating women. This research is needed by policy makers across the globe and inform WHO guidelines on the optimal weekly dose of folic acid needed, if any, to effectively prevent NTD-affected pregnancies. This study is a three-arm, parallel-group, randomised, placebo controlled trial with a 16 week intervention period followed by a 4 week washout period. The trail took place in Selangor, Malaysia. The results of the study are now avaialble and published in BMJ Global Health